Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Phil N. Newsome"'
Autor:
Eduardo Vilar-Gomez, Raj Vuppalanchi, Andrea Mladenovic, Niharika Samala, Samer Gawrieh, Phil N. Newsome, Naga Chalasani
Publikováno v:
Clinical Gastroenterology and Hepatology. 21:115-124.e7
The population prevalence of high-risk non-alcoholic steatohepatitis (NASH), defined as nonalcoholic fatty liver disease activity score ≥4 and fibrosis stage ≥2, is unknown. The FibroScan-AST (FAST) score, calculated using liver stiffness measure
Autor:
Raluca Pais, Rachel Ostroff, Stephen Harrison, Lars Friis Mikkelsen, Elisabeth Erhardtsen, Sudha Shankar, Kimmo Porthan, Jérôme Boursier, Antonia Sinisi, Michael Kalutkiewicz, Sven Francque, Miljen Martic, Vanessa Pellegrinelli, Phil N. Newsome, Guido Hanauer, Hannele Yki-Järvinen, Rebecca Darlay, Joel Myers, Carla Yunis, Salvatore Petta, Mette Skalshøi Kjær, Pablo Ortiz, Ann K. Daly, James H. Clark, Dina Tiniakos, Yasaman Vali, Hadi Zafarmand, Matej Orešič, Maurizio Parola, Estelle Sandt, Lori L. Jennings, Matt Kelly, Tuulia Hyötyläinen, Detlef Schuppan, Céline Fournier, Chiara Rosso, Diane E. Shevell, Maria Manuela Tonini, Paul Hockings, Aidan McGlinchey, Salma Akhtar, Mette Juul Fisker, Morten A. Karsdal, Diane Whalley, Melissa R. Miller, Aldo Trylesinski, Mattias Ekstedt, Stefan Neubauer, Jeremy M. Palmer, Partho Sen, Michael Pavlides, Per Qvist, Isabel Fernández, Luca Miele, Fabio Marra, Stergios Kechagias, Richard Torstenson, Katherine Johnson, Jean-François Dufour, Elisabetta Bugianesi, M. Julia Brosnan, George V. Papatheodoridis, Kay M. Pepin, Daniel Guldager Kring Rasmussen, Henrik Landgren, Rachel Queen, Simon Cockell, Michael Allison, Patrick M.M. Bossuyt, Rocío Gallego-Durán, Christian Rosenquist, Leigh Alexander, Elizabeth Shumbayawonda, Michele Vacca, Antonio Vidal-Puig, David Wenn, Rémy Hanf, Oscar Millet, Michalina Zatorska, R. Myers, José M. Mato, Jenny Lee, Theresa Tuthill, James Twiss, Ramy Younes, Peter Leary, Lynda Doward, Kristy Wonders, Guruprasad P. Aithal, Sarah Charlton, Vlad Ratziu, Cecília M. P. Rodrigues, Christian Trautwein, Helena Cortez-Pinto, Gideon Ho, Matt J. Barter, Judith Ertle, Jörn M. Schattenberg, Maria-Magdalena Balp, Yang-Lin Liu, Clifford A. Brass, Olivier Govaere, Amalia Gastaldelli, Sergio Rodriguez Cuenca, Pierre Chaumat, Fiona Oakley, Luca Valenti, Simon J. Cockell, Saskia W.C. van Mil, Ferenc E. Mózes, Andreas Geier, Timothy Hardy, Pierre Bedossa, Andrea Dennis, Richard L. Ehman, Charlotte Erpicum, Karine Clément, Jeremy F. L. Cobbold, Christopher P. Day, Rajarshi Banerjee, Manuel Romero-Gómez, Quentin M. Anstee, Adriaan G. Holleboom, Heather J. Cordell, Kevin L. Duffin, Diana Julie Leeming
Publikováno v:
JHEP Reports, 4(2):100409. Elsevier
JHEP Reports
JHEP Reports, Vol 4, Iss 2, Pp 100409-(2022)
JHEP reports 4(2), 100409 (2022). doi:10.1016/j.jhepr.2021.100409
JHEP Reports
JHEP Reports, Vol 4, Iss 2, Pp 100409-(2022)
JHEP reports 4(2), 100409 (2022). doi:10.1016/j.jhepr.2021.100409
Background & Aims Serum microRNA (miRNA) levels are known to change in non-alcoholic fatty liver disease (NAFLD) and may serve as useful biomarkers. This study aimed to profile miRNAs comprehensively at all NAFLD stages. Methods We profiled 2,083 ser
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c39a3a5921e0d464a7b2b93c40ef52c
https://pure.amc.nl/en/publications/increased-serum-mir193a5p-during-nonalcoholic-fatty-liver-disease-progression(bd6dd66c-d686-4b4d-be46-956a848f1f3b).html
https://pure.amc.nl/en/publications/increased-serum-mir193a5p-during-nonalcoholic-fatty-liver-disease-progression(bd6dd66c-d686-4b4d-be46-956a848f1f3b).html
Autor:
Tom H. Karlsen, Phil N. Newsome
Publikováno v:
Journal of hepatology. 71(1)
Autor:
Lozan, Sheriff, Asma, Alanazi, Lewis S C, Ward, Carl, Ward, Hafsa, Munir, Julie, Rayes, Mohammed, Alassiri, Steve P, Watson, Phil N, Newsome, G E, Rainger, Neena, Kalia, Jon, Frampton, Helen M, McGettrick, Gerard B, Nash
Publikováno v:
Stem Cells (Dayton, Ohio)
We investigated the adhesive behavior of mesenchymal stem cells (MSC) in blood, which might influence their fate when infused as therapy. Isolated human bone marrow MSC (BMMSC) or umbilical cord MSC (UCMSC) adhered efficiently from flow to the matrix
Autor:
Phil N. Newsome, Reenam Khan
Publikováno v:
In Clinical Practice ISBN: 9783319431253
A 46-year-old Caucasian male was referred to the gastroenterology clinic with abdominal distension and jaundice. His medical history included chronic obstructive pulmonary disease. He had a five pack-year smoking history and was a teetotaller. He had
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9477941ce59ed3f938a3bfc20baaabdd
https://doi.org/10.1007/978-3-319-43126-0_9
https://doi.org/10.1007/978-3-319-43126-0_9
Autor:
Joanna K. Dowman, Phil N. Newsome
Publikováno v:
Problem-Based Approach to Gastroenterology and Hepatology
Autor:
L. Walker, Laurence J. Hopkins, Phil N. Newsome, S. Dyer, Jon Frampton, Shankar Suresh, Diarmaid D. Houlihan, Wenbin Wei, M.C. Strachan, Anthony P. Hollander, KB Attridge, M. Griffiths, A. Owen, S. Zhang
Publikováno v:
Journal of Hepatology. 62:S783-S784
Publikováno v:
Journal of inherited metabolic disease. 37(5)
Tyrosinaemia type 1 (HT1) is a rare disorder of tyrosine metabolism leading to liver failure and hepatocellular carcinoma. Treatment previously consisted of dietary restriction and orthotopic liver transplantation (OLT) but was transformed by the int
Autor:
Phil N. Newsome, Jon Frampton, Gerard B. Nash, Helen M. McGettrick, G. Ed Rainger, N. Thin Luu, Christopher D. Buckley
Publikováno v:
Stem cells (Dayton, Ohio). 31(12)
Mesenchymal stem cells (MSC) have immunomodulatory properties, but their effects on endothelial cells (EC) and recruitment of leukocytes are unknown. We cocultured human bone marrow-derived MSC with EC and found that MSC could downregulate adhesion o
Autor:
Patrick J. McKiernan, Mary Anne Preece, Phil N. Newsome, Elisabeth Holme, David C. Bartlett, C. Lloyd
Publikováno v:
Journal of inherited metabolic disease. 36(1)
Tyrosinaemia type 1 (HT1) is a rare disorder leading to accumulation of toxic metabolites such as succinylacetone (SA) and a high risk of hepatocellular carcinoma. Children with HT1 traditionally required liver transplantation (OLT) and while the nee